mAb-labeled liposomes in breast cancer cell targeting. Therapeutics and diagnostic use of polyspecific artificial carriers.
Rombi
G
G
Istituto Radiologia, Università di Cagliari, Italy.
Cossu
F
F
Melis
G
G
D015060:1,2-Dipalmitoylphosphatidylcholine; D000911:Antibodies, Monoclonal; D001932:Brain Neoplasms / Q000000981:diagnostic imaging / Q000556:secondary*; D001943:Breast Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology / Q000601:surgery; D004337:Drug Carriers; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000008:administration & dosage; D008081:Liposomes; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000556:secondary*; D009362:Neoplasm Metastasis; D010714:Phosphatidylethanolamines; D016719:Radioimmunodetection / Q000379:methods*; D013667:Technetium / Q000008:administration & dosage
D000911:Antibodies, Monoclonal; D004337:Drug Carriers; D007457:Iodine Radioisotopes; D008081:Liposomes; D010714:Phosphatidylethanolamines; D015060:1,2-Dipalmitoylphosphatidylcholine; C007510:1,2-dipalmitoyl-3-phosphatidylethanolamine; D013667:Technetium